Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria (PRIMUS)

NCT07468526 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.

NCT NCT07468526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07468526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria (PRIMUS)
Lead sponsor
Menzies School of Health Research
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
April 1, 2028
Enrollment
1,019 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

malaria